Compare ATRA & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRA | MLEC |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.1M | 4.9M |
| IPO Year | 2014 | N/A |
| Metric | ATRA | MLEC |
|---|---|---|
| Price | $17.92 | $0.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $21.00 | N/A |
| AVG Volume (30 Days) | 71.6K | ★ 131.3K |
| Earning Date | 11-12-2025 | 01-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.97 | N/A |
| Revenue | ★ $151,930,000.00 | N/A |
| Revenue This Year | N/A | $20.42 |
| Revenue Next Year | N/A | $30.00 |
| P/E Ratio | $9.15 | ★ N/A |
| Revenue Growth | 51.27 | ★ 170.36 |
| 52 Week Low | $5.01 | $0.39 |
| 52 Week High | $18.71 | $8.00 |
| Indicator | ATRA | MLEC |
|---|---|---|
| Relative Strength Index (RSI) | 69.17 | 36.36 |
| Support Level | $14.37 | $0.41 |
| Resistance Level | $18.37 | $0.48 |
| Average True Range (ATR) | 1.19 | 0.05 |
| MACD | 0.49 | 0.01 |
| Stochastic Oscillator | 94.07 | 24.66 |
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.